(R)-3-Methylpyrrolidine-3-carboxylic acid

Catalog No.: 
ACMZRI694
CAS No.: 
1410783-77-5
Molecular Formula: 
C6H11NO2
Molecular Weight: 
129.16
(R)-3-Methylpyrrolidine-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$62.00In stockInquiry
250mg97%$75.00In stockIn stock
1g97%$283.00In stockIn stock
5g97%$1000.00In stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-3-Methylpyrrolidine-3-carboxylic acid
IUPAC Name(R)-3-methylpyrrolidine-3-carboxylic acid
MDL No.MFCD24368648
Molecular FormulaC6H11NO2
Molecular Weight129.16
SMILESO=C([C@@]1(C)CNCC1)O
InChI KeyJXNPHMVNQPDXQI-ZCFIWIBFSA-N
Synonym1410783-77-5 | (R)-3-Methyl-pyrrolidine-3-carboxylic acid | (R)-3-methylpyrrolidine-3-carboxylic acid | (3R)-3-methylpyrrolidine-3-carboxylic acid | SCHEMBL20293460 | MFCD24368648 | SB33354 | (R)-3-methylpyrrolidine-3-carboxylicacid | BS-15055 | CS-013380
CAS No.1410783-77-5
PubChem CID1516524

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACMZRI694 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYJLP405 route compound structure diagram
    ACYJLP4052198242-27-0In Stock
  2. Then
  3. ACMZRI694 route product structure diagram
    ACMZRI6941410783-77-5In Stock
Inquiry

2. ACMZRI694 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMZRI694 route product structure diagram
    ACMZRI6941410783-77-5In Stock
Inquiry

3. ACMZRI694 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMZRI694 route product structure diagram
    ACMZRI6941410783-77-5In Stock
Inquiry

Comments (0)